Skip to main content
Clinical Trials/TCTR20221226002
TCTR20221226002
Unknown
Phase 2

Efficacy of Vonoprazan based therapy (Vonoprazan, Amoxycillin, Levofloxacin) versus Omeprazole based standard therapy for Helicobacter Pylori: A Multicenter Randomized Controlled Trial

Phramongkutklao hospital0 sites158 target enrollmentStarted: December 26, 2022Last updated:

Overview

Phase
Phase 2
Enrollment
158

Overview

Brief Summary

No summary available.

Study Design

Study Type
Interventional

Eligibility Criteria

Ages
20 Years to N/A (No limit) (—)
Sex
All

Inclusion Criteria

  • Patients older than 20 year olds with H.pylori infection

Exclusion Criteria

  • History of H.pylori eradication
  • Drug allergy to amoxycillin, clarithromycin, levofloxacin, omeprazole or vonoprazan
  • Pregnancy or lactation
  • HIV infection patient
  • Active UGIB
  • Hemodynamic unstability
  • History of gastric cancer or surgery
  • Chronic lung disease
  • Active Tuberculosis infection

Investigators

Similar Trials